News Release

Notice Regarding Additional Contributions Accompanying the Continuation of the Performance-Based Stock Compensation System

Notice regarding additional contributions related to the continuation of Trust-type Stock Delivery System for Employees

Notice regarding the conclusion of an agreement for Tsumura China Inc. to acquire an interest in Shanghai Hongqiao Traditional Chinese Drug Pieces Co., Ltd.

Notice Concerning the Status and Conclusion of Share Repurchase

2nd Medium-Term Management Plan (FY2025 - FY2027)

Notice regarding the continuation of Trust-type Stock Delivery System for Employees

Notice regarding partial revision of the Performance-Based Stock Compensation System

Notice Concerning Status of Share Repurchases

Notice Concerning Status of Share Repurchases

Notice of Decision on Offer Price, etc.

(Progress of Disclosed Matters) Notice of Decision on Matters Relating to Purchase of Treasury Shares

Notice of Sale of Shares

Notice of Decision on Matters Relating to Purchase of Treasury Shares

Tsumura Announces Revision of Earnings Forecast

Tsumura Announces Conclusion of Letter of Intent between Ping An Tsumura Inc. and Shanghai Hongqiao Pharmaceutical Co., Ltd.

Notice Concerning Dividends of Surplus (Dividend Increase)

Notice Concerning Revision of Basic Capital Management Policy and Shareholder Return Policy and Revision of Dividends Projection (Dividend Increase)

Tsumura Announces Revision of Earnings Forecast

Tsumura Announces Conclusion of Agreement Regarding Acquisition of Equity Interest in Shaanxi Unisplendour Life Care Pharmaceutical Co., Ltd. by Ping An Tsumura Inc.

Tsumura Announces Introduction of Trust-type Stock Delivery System for Employees

Tsumura Announces Signing of Letter of Intent Concerning Establishment of Joint Venture with Jianmin Pharmaceutical Group Co., Ltd.

Tsumura Announces Establishment of PINGAN TSUMURA TRADITIONAL CHINESE MEDICINE TECHNOLOGY CO., LTD.

Tsumura Announces Revision of Earnings Forecast

Tsumura Announces Completion of Payment for Disposition of Treasury Shares for Performance-Based Stock Compensation

Tsumura Announces Disposition of Treasury Shares for Performance-Based Stock Compensation

1st Medium-Term Management Plan (FY2022 - FY2024)

Tsumura Announces Revision of Performance-Based Stock Compensation System

Notice Regarding Partial Amendment of the Articles of Incorporation

Announces Revision of Earnings Forecast

Tsumura Announces Conclusion of Agreement Regarding Acquisition of Equity Interest in Tianjin China Medico Technology CO., Ltd. by Ping An Tsumura Inc.

Tsumura Announces Establishment of Capital Alliance with Tianjin China Medico Technology Co., Ltd. by Ping An Tsumura Inc.

Tsumura Announces Establishment of Conclusion of Letter of Intent for Capital Alliance with Tianjin China Medico Technology Co., Ltd. by Ping An Tsumura Inc.

Tsumura Announces Dissolution and Liquidation of its Joint Venture in China

Tsumura Announces Completion of Payment for Disposition of Treasury Shares for Performance-Based Stock Compensation

Tsumura Announces Disposition of Treasury Shares for Performance-Based Stock Compensation

Third Medium-Term Management Plan (Fiscal 2019 - Fiscal 2021)

Tsumura Announces Completion of Establishment of Joint Venture (Report of Progress)

Capital and Business Alliance with MYFARM

Tsumura to Hold Presentation on Vision for Business in China

Oil Spill at Takikawa Farm (Takikawa City, Hokkaido)

Tsumura Announces Execution of Joint Venture Agreement with Ping An Insurance (Group) Company of China, Ltd.

Tsumura Announces Execution of Joint Venture Agreement with Tianjin China Medico Technology Co., Ltd.

Notice of Completion of Payment for Issuing of New Shares and Disposal of Treasury Shares Through Third-Party Allotment

Tsumura Announces Capital and Business Alliance with Ping An Insurance (Group) Company of China, Ltd.,Issuance of New Shares and Disposal of Treasury Shares by Way of Third-Party Allotment,and Planned Change in Largest Shareholder Among Majo

Notice Regarding Issuance of Unsecured Bonds

Notice Regarding Executive Appointments after Transition to Company with Audit and Supervisory Committee

Notice Regarding Partial Amendments to the Articles of Incorporation

Tsumura Announces Transition to Company with Audit and Supervisory Committee

Tsumura Announces Establishment of Tsumura China Inc.

Notice Regarding Acquisition of Treasury Stock and Completion of Acquisition

Notice Regarding Acquisition of Treasury Stock

Notice Regarding Acquisition of Treasury Stock

Tsumura Announces Decision on Matters Related to Acquisition of Treasury Stock

Tsumura Announces Introduction of Performance-Linked Stock Compensation Plan

Tsumura Announces Change of Certified Public Accountant

Tsumura Announces Medium-Term Management Plan for FY 2016 to FY 2021

Tsumura Enters into a Business Collaboration Agreement with Tianjin China Medico Technology Co., Ltd. (China)

Tsumura Announces Establishment of a Joint Venture in China

Impact of the 2016 Earthquake in Kyusyu, Japan

The British journal Nature issues a press release on an experimental study on "TSUMURA Rikkunshito" Extract Granules for Ethical Use

Tsumura Announces Personnel Changes in Officers and Changes in Governance System

Tsumura Announces Full-scale Launch of its Farm Operations by Making Yubari Tsumura into an Agricultural Production Corporation

Tsumura Announces Inspection by Minister of Health, Labour and Welfare, Norihisa Tamura

Tsumura enters a Sponsorship Agreement for the "University of Oxford Innovative Systems Biology Project sponsored by Tsumura"

Regarding Support in Respect of Damage from Sichuan Earthquake

TSUMURA Announces Revised (Increased) Year-End Dividend Forecast for Term Ending March 2013

Tsumura Develops Medium-Term Management Plan for FY2012 to FY2015

TSUMURA Announces Partial Amendments to Articles of Incorporation

TSUMURA Announces Change in the Office of the President & Representative Director

LAO TSUMURA Recognized for Prospective Contribution to Laos

TSUMURA Announces Distribution of Dividends

Regarding the Resumption of Kampo Formulations Chief Plant Damaged by the Great East Japan Earthquake

Tsumura Establishes Technology for Cultivating Licorice Product of Joint Research with Chinese Groups and University

Recovering Condition of the Damage from "the 2011 Great East Japan Earthquake"

Impact from "the 2011 Great East Japan Earthquake"

Regarding the monetary donation, etc. from Chinese business partners. Tsumura & Co.

Regarding the Public Donation of Tsumura & Co. for "the 2011 off the Pacific coast of Tohoku Earthquake"

Tsumura Announces Increased Interim Dividends and Revised Year-End Dividend Forecast for Term Ending March 2011

Tsumura Revises Medium-Term Management Plan (Consolidated)

Tsumura Establishes a Local Corporation in Laos

Termination of Sales of Oral Contraceptive Agent, Synphase T28 Tablet

Tsumura Announces Increased Interim Dividends and Revised Year-End Dividend Forecast for Term Ending March 2010

Tsumura Establishes a Subsidiary for Botanicals Business in Hokkaido

Tsumura Provides Three OTC Kampo Formulations to Takeda Pharmaceutical Company Limited.

Notice of Abolition of Shareholder Special Benefit Plan

Tsumura Announces Medium-Term Management Plan for FY 2009 to FY 2011(Consolidated)

Tsumura Establishes Production, Processing and Storage Facility for Raw Medicinal Herbs in Yubari City, Hokkaido

About the transfer of approval to production and marketing of ASTAT®, an external-use, anti-fungal drug for ethical use

Tsumura Revises Earning Forecast

Tsumura Revises Dividend Forecast for Fiscal Year Ending March 2009 (73rd Term)

Transfer of Shares in Tsumura Lifescience Co., Ltd.

Tsumura Revises Year-End Dividend Forecast (Dividend Increase) for Fiscal Year Ending March 2008 (72nd Term)

Notice Regarding Transfer of Shares in Overseas Subsidiary

Tsumura to Discontinue Development of TU-025 (Keishibukuryogan) in the U.S.

Tsumura Announces Medium-Term Management Plan for FY 2007 to FY 2009 (Consolidated)

Notice of Partial Change of Shareholder Special Benefit Plan

Notice of Change in Number of Shares per Stock Trading Unit

Announcement on the Development of TU-025 (Keishibukuryogan) in the U.S.